Medicine Access Programmes: what do patients think – a patient‐reported outcome study on ribociclib in metastatic breast cancer in Australia

This study evaluated patient-reported outcomes (PROs) of Medicine Access Programmes (MAPs) for Australian metastatic breast cancer patients on ribociclib. Limited patient awareness of MAP enrolment was identified, emphasising the need for improved education and consent processes. Most patients expressed gratitude for accessing non-funded medications and perceived enhanced medication adherence as a key benefit. Integrating PRO data with real-world registry data provides comprehensive insight for future MAP development.

Authors

Institutions

Publication Details

Journal
Internal Medicine Journal
Published
2024-10-28
DOI
https://doi.org/10.1111/imj.16536
Citations
1
Primary Topic
Advanced Breast Cancer Therapies
Type
article
Field-Weighted Citation Impact
0.42
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Medicine Access Programmes: what do patients think – a patient‐reported outcome study on ribociclib in metastatic breast cancer in Australia

Sally E. Baron-Hay, Michelle Nottage, Louise Nott, Vanessa Wong et al.
1 citations
Internal Medicine Journal
Advanced Breast Cancer Therapies
0.42
article

Medicine Access Programmes: what do patients think – a patient‐reported outcome study on ribociclib in metastatic breast cancer in Australia

Sally E. Baron-Hay, Michelle Nottage, Louise Nott, Vanessa Wong, Robert helmut Blum, Sheau Wen Lok, Anthony Uccellini, Benjamin Forster, Peter Gibbs, Katharine Cuff, Ali Tafreshi, Catherine Morton, Elgene Lim, Michael Green, Richard de Boer, Daphne Tsoi, Kelly Mok, N. Y. Yap, Susan Chua, Kerrie Clarke
article en
1 citations

Abstract

This study evaluated patient-reported outcomes (PROs) of Medicine Access Programmes (MAPs) for Australian metastatic breast cancer patients on ribociclib. Limited patient awareness of MAP enrolment was identified, emphasising the need for improved education and consent processes. Most patients expressed gratitude for accessing non-funded medications and perceived enhanced medication adherence as a key benefit. Integrating PRO data with real-world registry data provides comprehensive insight for future MAP development.

Internal Medicine JournalVol. 54(11)
St John of God Subiaco Hospital (AU), Mater Health Services (AU), The Royal Melbourne Hospital (AU), Walter and Eliza Hall Institute of Medical Research (AU), Royal Brisbane and Women's Hospital (AU), Epworth Hospital (AU), Peter MacCallum Cancer Centre (AU), Liverpool Hospital (AU), Wollongong Hospital (AU), Princess Alexandra Hospital (AU), Royal Hobart Hospital (AU), Eastern Health (AU), St Vincent’s Private Hospital Sydney (AU), Western Health (AU), Albury Wodonga Health (AU), Northern Cancer Institute (AU), St John of God Hospital (AU), Bendigo Health (AU), The Kinghorn Cancer Centre (AU), Olivia Newton-John Cancer Wellness & Research Centre (AU), Austin Health (AU)
Openalex Percentile: Top 31%
Advanced Breast Cancer Therapies
0.42
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.